Personalized Medicines In Oncology Market, Global Outlook and Forecast 2023-2028

Report ID: 1134854 | Published Date: Jan 2025 | No. of Page: 69 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Personalized Medicines In Oncology Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Personalized Medicines In Oncology Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Personalized Medicines In Oncology Overall Market Size
    2.1 Global Personalized Medicines In Oncology Market Size: 2021 VS 2028
    2.2 Global Personalized Medicines In Oncology Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Personalized Medicines In Oncology Players in Global Market
    3.2 Top Global Personalized Medicines In Oncology Companies Ranked by Revenue
    3.3 Global Personalized Medicines In Oncology Revenue by Companies
    3.4 Top 3 and Top 5 Personalized Medicines In Oncology Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Personalized Medicines In Oncology Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Personalized Medicines In Oncology Players in Global Market
        3.6.1 List of Global Tier 1 Personalized Medicines In Oncology Companies
        3.6.2 List of Global Tier 2 and Tier 3 Personalized Medicines In Oncology Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Personalized Medicines In Oncology Market Size Markets, 2021 & 2028
        4.1.2 Molecular Oncopathology
        4.1.3 Genome Diagnostics
        4.1.4 Radiation Therapy
        4.1.5 Oncology Testing
        4.1.6 Chemotherapy
        4.1.7 Others
    4.2 By Type - Global Personalized Medicines In Oncology Revenue & Forecasts
        4.2.1 By Type - Global Personalized Medicines In Oncology Revenue, 2017-2022
        4.2.2 By Type - Global Personalized Medicines In Oncology Revenue, 2023-2028
        4.2.3 By Type - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Personalized Medicines In Oncology Market Size, 2021 & 2028
        5.1.2 Research Centers
        5.1.3 Governmental Institutions
        5.1.4 Hospitals
        5.1.5 Clinical Centers
        5.1.6 Others
    5.2 By Application - Global Personalized Medicines In Oncology Revenue & Forecasts
        5.2.1 By Application - Global Personalized Medicines In Oncology Revenue, 2017-2022
        5.2.2 By Application - Global Personalized Medicines In Oncology Revenue, 2023-2028
        5.2.3 By Application - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Personalized Medicines In Oncology Market Size, 2021 & 2028
    6.2 By Region - Global Personalized Medicines In Oncology Revenue & Forecasts
        6.2.1 By Region - Global Personalized Medicines In Oncology Revenue, 2017-2022
        6.2.2 By Region - Global Personalized Medicines In Oncology Revenue, 2023-2028
        6.2.3 By Region - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Personalized Medicines In Oncology Revenue, 2017-2028
        6.3.2 US Personalized Medicines In Oncology Market Size, 2017-2028
        6.3.3 Canada Personalized Medicines In Oncology Market Size, 2017-2028
        6.3.4 Mexico Personalized Medicines In Oncology Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Personalized Medicines In Oncology Revenue, 2017-2028
        6.4.2 Germany Personalized Medicines In Oncology Market Size, 2017-2028
        6.4.3 France Personalized Medicines In Oncology Market Size, 2017-2028
        6.4.4 U.K. Personalized Medicines In Oncology Market Size, 2017-2028
        6.4.5 Italy Personalized Medicines In Oncology Market Size, 2017-2028
        6.4.6 Russia Personalized Medicines In Oncology Market Size, 2017-2028
        6.4.7 Nordic Countries Personalized Medicines In Oncology Market Size, 2017-2028
        6.4.8 Benelux Personalized Medicines In Oncology Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Personalized Medicines In Oncology Revenue, 2017-2028
        6.5.2 China Personalized Medicines In Oncology Market Size, 2017-2028
        6.5.3 Japan Personalized Medicines In Oncology Market Size, 2017-2028
        6.5.4 South Korea Personalized Medicines In Oncology Market Size, 2017-2028
        6.5.5 Southeast Asia Personalized Medicines In Oncology Market Size, 2017-2028
        6.5.6 India Personalized Medicines In Oncology Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Personalized Medicines In Oncology Revenue, 2017-2028
        6.6.2 Brazil Personalized Medicines In Oncology Market Size, 2017-2028
        6.6.3 Argentina Personalized Medicines In Oncology Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Personalized Medicines In Oncology Revenue, 2017-2028
        6.7.2 Turkey Personalized Medicines In Oncology Market Size, 2017-2028
        6.7.3 Israel Personalized Medicines In Oncology Market Size, 2017-2028
        6.7.4 Saudi Arabia Personalized Medicines In Oncology Market Size, 2017-2028
        6.7.5 UAE Personalized Medicines In Oncology Market Size, 2017-2028
7 Players Profiles
    7.1 Biotheranostics
        7.1.1 Biotheranostics Corporate Summary
        7.1.2 Biotheranostics Business Overview
        7.1.3 Biotheranostics Personalized Medicines In Oncology Major Product Offerings
        7.1.4 Biotheranostics Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.1.5 Biotheranostics Key News
    7.2 Illumina
        7.2.1 Illumina Corporate Summary
        7.2.2 Illumina Business Overview
        7.2.3 Illumina Personalized Medicines In Oncology Major Product Offerings
        7.2.4 Illumina Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.2.5 Illumina Key News
    7.3 DNA Link
        7.3.1 DNA Link Corporate Summary
        7.3.2 DNA Link Business Overview
        7.3.3 DNA Link Personalized Medicines In Oncology Major Product Offerings
        7.3.4 DNA Link Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.3.5 DNA Link Key News
    7.4 Genomic Health, Inc.(Exact Sciences)
        7.4.1 Genomic Health, Inc.(Exact Sciences) Corporate Summary
        7.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
        7.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Major Product Offerings
        7.4.4 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.4.5 Genomic Health, Inc.(Exact Sciences) Key News
    7.5 Cypher Genomics(Human Longevity, Inc.)
        7.5.1 Cypher Genomics(Human Longevity, Inc.) Corporate Summary
        7.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
        7.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Major Product Offerings
        7.5.4 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.5.5 Cypher Genomics(Human Longevity, Inc.) Key News
    7.6 Life Technologies Corporation(Thermo Fisher Scientific)
        7.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Corporate Summary
        7.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
        7.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Major Product Offerings
        7.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Key News
    7.7 Fulgent Genetics
        7.7.1 Fulgent Genetics Corporate Summary
        7.7.2 Fulgent Genetics Business Overview
        7.7.3 Fulgent Genetics Personalized Medicines In Oncology Major Product Offerings
        7.7.4 Fulgent Genetics Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.7.5 Fulgent Genetics Key News
    7.8 Caris Life Sciences
        7.8.1 Caris Life Sciences Corporate Summary
        7.8.2 Caris Life Sciences Business Overview
        7.8.3 Caris Life Sciences Personalized Medicines In Oncology Major Product Offerings
        7.8.4 Caris Life Sciences Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.8.5 Caris Life Sciences Key News
    7.9 Ariana Pharma
        7.9.1 Ariana Pharma Corporate Summary
        7.9.2 Ariana Pharma Business Overview
        7.9.3 Ariana Pharma Personalized Medicines In Oncology Major Product Offerings
        7.9.4 Ariana Pharma Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.9.5 Ariana Pharma Key News
    7.10 Abbott Laboratories
        7.10.1 Abbott Laboratories Corporate Summary
        7.10.2 Abbott Laboratories Business Overview
        7.10.3 Abbott Laboratories Personalized Medicines In Oncology Major Product Offerings
        7.10.4 Abbott Laboratories Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.10.5 Abbott Laboratories Key News
    7.11 deCODE genetics
        7.11.1 deCODE genetics Corporate Summary
        7.11.2 deCODE genetics Business Overview
        7.11.3 deCODE genetics Personalized Medicines In Oncology Major Product Offerings
        7.11.4 deCODE genetics Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.11.5 deCODE genetics Key News
    7.12 Exagen Inc
        7.12.1 Exagen Inc Corporate Summary
        7.12.2 Exagen Inc Business Overview
        7.12.3 Exagen Inc Personalized Medicines In Oncology Major Product Offerings
        7.12.4 Exagen Inc Personalized Medicines In Oncology Revenue in Global Market (2017-2022)
        7.12.5 Exagen Inc Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Personalized Medicines In Oncology Market Opportunities & Trends in Global Market
    Table 2. Personalized Medicines In Oncology Market Drivers in Global Market
    Table 3. Personalized Medicines In Oncology Market Restraints in Global Market
    Table 4. Key Players of Personalized Medicines In Oncology in Global Market
    Table 5. Top Personalized Medicines In Oncology Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Personalized Medicines In Oncology Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Personalized Medicines In Oncology Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Personalized Medicines In Oncology Product Type
    Table 9. List of Global Tier 1 Personalized Medicines In Oncology Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Personalized Medicines In Oncology Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Personalized Medicines In Oncology Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Personalized Medicines In Oncology Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Personalized Medicines In Oncology Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Personalized Medicines In Oncology Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Personalized Medicines In Oncology Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Personalized Medicines In Oncology Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Personalized Medicines In Oncology Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Personalized Medicines In Oncology Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Personalized Medicines In Oncology Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Personalized Medicines In Oncology Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Personalized Medicines In Oncology Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Personalized Medicines In Oncology Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Personalized Medicines In Oncology Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Personalized Medicines In Oncology Revenue, (US$, Mn), 2023-2028
    Table 30. Biotheranostics Corporate Summary
    Table 31. Biotheranostics Personalized Medicines In Oncology Product Offerings
    Table 32. Biotheranostics Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 33. Illumina Corporate Summary
    Table 34. Illumina Personalized Medicines In Oncology Product Offerings
    Table 35. Illumina Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 36. DNA Link Corporate Summary
    Table 37. DNA Link Personalized Medicines In Oncology Product Offerings
    Table 38. DNA Link Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 39. Genomic Health, Inc.(Exact Sciences) Corporate Summary
    Table 40. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Offerings
    Table 41. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 42. Cypher Genomics(Human Longevity, Inc.) Corporate Summary
    Table 43. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Offerings
    Table 44. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 45. Life Technologies Corporation(Thermo Fisher Scientific) Corporate Summary
    Table 46. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Offerings
    Table 47. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 48. Fulgent Genetics Corporate Summary
    Table 49. Fulgent Genetics Personalized Medicines In Oncology Product Offerings
    Table 50. Fulgent Genetics Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 51. Caris Life Sciences Corporate Summary
    Table 52. Caris Life Sciences Personalized Medicines In Oncology Product Offerings
    Table 53. Caris Life Sciences Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 54. Ariana Pharma Corporate Summary
    Table 55. Ariana Pharma Personalized Medicines In Oncology Product Offerings
    Table 56. Ariana Pharma Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 57. Abbott Laboratories Corporate Summary
    Table 58. Abbott Laboratories Personalized Medicines In Oncology Product Offerings
    Table 59. Abbott Laboratories Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 60. deCODE genetics Corporate Summary
    Table 61. deCODE genetics Personalized Medicines In Oncology Product Offerings
    Table 62. deCODE genetics Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
    Table 63. Exagen Inc Corporate Summary
    Table 64. Exagen Inc Personalized Medicines In Oncology Product Offerings
    Table 65. Exagen Inc Personalized Medicines In Oncology Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Personalized Medicines In Oncology Segment by Type in 2021
    Figure 2. Personalized Medicines In Oncology Segment by Application in 2021
    Figure 3. Global Personalized Medicines In Oncology Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Personalized Medicines In Oncology Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Personalized Medicines In Oncology Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Personalized Medicines In Oncology Revenue in 2021
    Figure 8. By Type - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    Figure 12. US Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    Figure 16. Germany Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 17. France Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    Figure 24. China Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 28. India Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    Figure 30. Brazil Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Personalized Medicines In Oncology Revenue Market Share, 2017-2028
    Figure 33. Turkey Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Personalized Medicines In Oncology Revenue, (US$, Mn), 2017-2028
    Figure 37. Biotheranostics Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Illumina Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. DNA Link Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Fulgent Genetics Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Caris Life Sciences Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Ariana Pharma Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Abbott Laboratories Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. deCODE genetics Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Exagen Inc Personalized Medicines In Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
69
Frequently Asked Questions
Personalized Medicines In Oncology Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Personalized Medicines In Oncology Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Personalized Medicines In Oncology Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports